Abbott Laboratories
Food industry company news
Latest Insights
Tackling infant formula fraud in China
A fresh scandal has brought the sale of fraudulent infant formula in China to the fore once again in recent weeks. Mark Godfrey examines wha...
Latest News
US pharma group Abbott Laboratories has reported a rise in second-quarter sales from its paediatric nutrition division, although the increase was not enough to stem a fall in the first half of the year.
US pharma group Abbott Laboratories today (19 April) reported a fall in first-quarter sales from its paediatric nutrition business, hit by "challenging" conditions in China's infant formula market.
US pharma group Abbott Laboratories saw sales from its nutrition business - which includes infant formula - fall in 2016, with the decline accelerating in the fourth quarter amid challenges in China and Saudi Arabia.
US pharma-to-nutrition group Abbott Laboratories has reported a drop in third-quarter nutritional sales as declining international revenue offset growth in the company's domestic operations
US infant formula and pharma group Abbott Laboratories has extended its Curate bar snacking range to target children in the US.
Abbott Laboratories reported higher comparable sales at its infant nutrition unit in the first quarter of this year thanks to the contribution from newly launched products.
China's latest infant formula counterfeiting scandal has drawn in brands owned by the country's largest milk powder manufacturer, Beingmate Baby & Child Food Co.
Shanghai food safety authorities have confirmed six arrests have been made over the alleged production and sale of fake milk powder under the Abbott brand name in China.
US nutritionals-to-pharma group Abbott Laboratories is planning to double down on its presence in the US snacking sector.
US infant formula and pharma group Abbott Laboratories has announced the launch of a snack bar line to cater to growing demand for "nutritious" snacks that have "rich, complex flavours".
Sales in Abbott Laboratories' nutritional division rose in 2015, helped by the launch of more products.
A jump in sales in its nutrition arm has seen Abbott Laboratories post an increase in sales and profits overall for the first nine months of the year.
Abbott Laboratories is facing a class action lawsuit over its Similac infant formula that alleges the US group is "misleading" consumers since the product contains non-organic ingredients.
US infant formula group Abbott Laboratories has launched what it claims to be the "first and only" GMO-free infant formula from a "leading" manufacturer, Similac Advance Non-GMO.
Abbott Laboratories has opened a new plant in India manufacturing products from infant formula to nutritional shakes for adults.
Most Popular
Insights
- Focus: McCormick's spicy move for Reckitt's sauces
- How the food industry can reverse climate change
- Interview: Intersnack on move for Butterkist
- UK choc upstart Doisy & Dam on sustainability
- In-depth: Prospects for direct-to-consumer in UK
News
- PE firms 'circling Unilever spreads division'
- Unilever prepared to strike more M&A in food
- Ferrero 'mulling move for Nestle US candy unit'
- UK snacks firm Graze 'being prepared for sale'
- Ferrara 'eyeing Nestle's US confectionery brands'
Market research
Get full access
